Publication Cover
Redox Report
Communications in Free Radical Research
Volume 21, 2016 - Issue 5
1,102
Views
25
CrossRef citations to date
0
Altmetric
Research article

Decreased expression of heme oxygenase is associated with depressive symptoms and may contribute to depressive and hypertensive comorbidity

, , , , , & show all

Figures & data

Figure 1 Concentration of H2O2 in plasma of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.001.

Figure 1 Concentration of H2O2 in plasma of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.001.

Figure 2 Concentration of MDA in erythrocytes of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.001.

Figure 2 Concentration of MDA in erythrocytes of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.001.

Figure 3 Concentration of GSH in whole blood of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.01.

Figure 3 Concentration of GSH in whole blood of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.01.

Figure 4 Activity of GR in erythrocytes of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.01.

Figure 4 Activity of GR in erythrocytes of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.01.

Figure 5 Activity of GPx-1 in erythrocytes of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.001.

Figure 5 Activity of GPx-1 in erythrocytes of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.001.

Figure 6 Activity of SOD-1 in erythrocytes of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.001.

Figure 6 Activity of SOD-1 in erythrocytes of patients with depression (n = 15), hypertension (n = 20), and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.001.

Figure 7 Concentration of HO-1 in serum of patients with depression (n = 15), hypertension (n = 20) and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.005.

Figure 7 Concentration of HO-1 in serum of patients with depression (n = 15), hypertension (n = 20) and hypertension with comorbid depression (n = 16) compared with controls (n = 19); *P < 0.005.

Figure 8 Scatter plot of BDI against HO-1 in study population. BDI – Beck Depression Inventory; HO-1 – heme oxygenase.

Figure 8 Scatter plot of BDI against HO-1 in study population. BDI – Beck Depression Inventory; HO-1 – heme oxygenase.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.